共 109 条
[1]
Kopecek J.(2000)HPMA copolymer-anticancer drug conjugates: design, activity and mechanism of action Eur. J. Pharm. Biopharm. 50 61-81
[2]
Kopeckova P.(2002)Design of novel bioconjugates for targeted drug delivery J. Control. Rel. 78 165-173
[3]
Minko T.(2003)The dawning era of polymer therapeutics Nat. Rev. Drug Discov. 2 347-360
[4]
Lu Z. R.(2001)Synthetic macromolecular drug carriers: biodistribution of poly [(N-2-hydroxypropyl) methacrylamide] copolymers and their accumulation in solid rat tumors PDA J. Pharm. Sci. & Tech. 55 191-201
[5]
Lu Z.-R.(1996)Gamma scintigraphy of J. Drug Targ. 3 385-390
[6]
Shiah J-G(1993)I labeled N-(2-hydroxypropyl) methacrylamide copolymer doxorubicin conjugate containing galactosamine following intravenous administration to nude mice bearing hepatic human colon carcinoma J. Nucl. Med. 34 2253-2263
[7]
Sakumma S.(2001)A ticket to ride: peptide radiopharmaceuticals Sem. Nuc. Med. 31 260-277
[8]
Kopeckova P.(1990)Evolution of Tc-99m in diagnostic radiopharmaceuticals Intl. J. Peptide Protein Res. 35 161-214
[9]
Kopecek J.(1978)Solid phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids Angew. Makromol. Chem. 70 109-118
[10]
Duncan R.(1977)Poly N-(2-hydroxypropyl) methacrylamide. 4. Heterogeneous polymerization Macromol. Chem. 178 2159-2168